Trial Profile
The study about the mechanism of action of omega-3 polyunsaturated fatty acids(EPA)
Status:
Not yet recruiting
Phase of Trial:
Phase IV
Latest Information Update: 08 Jan 2013
Price :
$35
*
At a glance
- Drugs Ethyl eicosapentaenoic acid (Primary)
- Indications Cardiovascular disorders; Depressive disorders; Embolism and thrombosis; Huntington's disease; Lipid metabolism disorders
- Focus Pharmacodynamics; Pharmacogenomic
- 08 Jan 2013 New trial record